BioCentury
ARTICLE | Financial News

Gore Range closes its inaugural fund

January 18, 2019 8:40 PM UTC

Gore Range Capital closed Fund I on Jan. 14. The firm declined to disclose how much Fund I raised.

Fund I has made 13 investments, including in neuroscience and immuno-oncology company BioXcel Therapeutics Inc. (NASDAQ:BTAI) and dermatology and women's health company Or-Genix Therapeutics Inc. (Worcester, Mass.)...

BCIQ Company Profiles

BioXcel Therapeutics Inc.